Publications for Leslie Citrome nntman@gmail.com
Citrome, L. (2015). Transdermal patches: How common are application site reactions and how severe are they? International Journal of Clinical Practice, 69(5), 509-510. doi:10.1111/ijcp.12668
Citrome, L. (2015). Vilazodone, levomilnacipran and vortioxetine for major depressive disorder: The 15-min challenge to sort these agents out. International Journal of Clinical Practice, 69(2), 151-155. doi:10.1111/ijcp.12620
Citrome, L. (2015). What is good publication practice, what is ISMPP, and why you should care. International Journal of Clinical Practice, 69(9), 913-914. doi:10.1111/ijcp.12725
Citrome, L., & Ketter, T. A. (2015). Number needed to treat can be helpful: A response to Andrade. The Journal of Clinical Psychiatry, 76(9), e1136-e1137. doi:10.4088/JCP.15lr10001
Citrome, L., & Ketter, T. A. (2015). Pharmacotherapy for bipolar depression: Comparative efficacy and acceptability is in the eye of the beholder. Evidence-Based Mental Health, 18(3) [Article 88]. doi:10.1136/eb-2015-102062
Citrome, L., & Volavka J (2015). Preventing violence in patients with schizophrenia. Current Treatment Options in Psychiatry, 2(2), 182-191. doi:10.1007/s40501-015-0039-4
Citrome, L., Eramo, A., Francois, C., Duffy, R., Legacy, S. N., Offord, S. J., . . . Rohman, P. (2015). Lack of tolerable treatment options for patients with schizophrenia. Neuropsychiatric Disease and Treatment, 11, 3095-3104. doi:10.2147/NDT.S91917
Citrome, L., Gommoll, C. P., Tang, X., Nunez, R., & Mathews, M. (2015). Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: Post-hoc analyses of a phase IV trial. International Clinical Psychopharmacology, 30(2), 75-81. doi:10.1097/YIC.0000000000000056
Citrome, L., Stensbol, T. B., & Maeda, K. (2015). The preclinical profile of brexpiprazole: What is its clinical relevance for the treatment of psychiatric disorders? Expert Review of Neurotherapeutics, 15(10), 1219-1229. doi:10.1586/14737175.2015.1086269
Citrome, L., Weiden, P. J., Alva, G., Glick, I. D., Jackson, R., Mattingly, G., . . . Winseck, A. (2015). Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophrenia. Clinical Schizophrenia & Related Psychoses, 8(4), 183-195. doi:10.3371/CSRP.CIWE.103114
Czobor, P., Van Dorn, R. A., Citrome, L., Kahn, R. S., Fleischhacker, W. W., & Volavka, J. (2015). Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies. European Neuropsychopharmacology, 25(8), 1158-1166. doi:10.1016/j.euroneuro.2015.04.003
Goldberg, J. F., Freeman, M. P., Balon, R., Citrome, L., Thase, M. E., Kane, J. M., & Fava, M. (2015). The American Society of Clinical Psychopharmacology survey of psychopharmacologists' practice patterns for the treatment of mood disorders. Depression and Anxiety, 32(8), 605-613. doi:10.1002/da.22378
Greenberg, W. M., & Citrome, L. (2015). Paliperidone palmitate for schizoaffective disorder: A review of the clinical evidence. Neurology and Therapy, 4(2), 81-91. doi:10.1007/s40120-015-0030-4
Levitan, B., Markowitz, M., Mohamed, A. F., Johnson, F. R., Alphs, L., Citrome, L., & Bridges, J. F. (2015). Patients' preferences related to benefits, risks, and formulations of schizophrenia treatment. Psychiatric Services, 66(7), 719-726. doi:10.1176/appi.ps.201400188
Loebel, A., & Citrome, L. (2015). Lurasidone: A novel antipsychotic agent for the treatment of schizophrenia and bipolar depression. BJPsych Bulletin, 39(5), 237-241. doi:10.1192/pb.bp.114.048793
Loebel, A., Citrome, L., Correll, C. U., Xu, J., Cucchiaro, J., & Kane, J. M. (2015). Treatment of early non-response in patients with schizophrenia: Assessing the efficacy of antipsychotic dose escalation. BMC Psychiatry, 15(1), 271. doi:10.1186/s12888-015-0629-0
Pahlajani, S., & Citrome, L. (2015). Liraglutide subcutaneous injection for weight loss: Where does it fit? International Journal of Clinical Practice, 69(7), 719-721. doi:10.1111/ijcp.12692
Volavka, J., & Citrome, L. (2015). Preventing violence in patients with schizophrenia. Current Treatment Options in Psychiatry, 2(2), 182-191. doi:10.1007/s40501-015-0039-4
Citrome, L. (2014). Antipsychotics and diabetes: Observational data. In Diapedia: The living textbook of diabetes. Driebit, Amsterdam: European Association for the Study of Diabetes. http://www.diapedia.org/associated-disorders/6104776169/antipsychotics-and-diabetes-observational-data;
Citrome, L. (2014). Are you a sunshine superman? The US Sunshine Act and reporting requirements. International Journal of Clinical Practice, 68(10), 1175-1176. doi:10.1111/ijcp.12539
Citrome, L. (2014). Asenapine review, part I: Chemistry, receptor affinity profile, pharmacokinetics and metabolism. Expert Opinion on Drug Metabolism & Toxicology, 10(6), 893-903. doi:10.1517/17425255.2014.908185
Citrome, L. (2014). Asenapine review, part II: Clinical efficacy, safety and tolerability. Expert Opinion on Drug Safety, 13(6), 803-830. doi:10.1517/14740338.2014.908183
Citrome, L. (2014). Beyond PubMed: Searching the "Grey Literature" for clinical trial results. Innovations in Clinical Neuroscience, 11(7-8), 42-46.
Citrome, L. (2014). Lorcaserin, phentermine topiramate combination, and naltrexone bupropion combination for weight loss: The 15-min challenge to sort these agents out. International Journal of Clinical Practice, 68(12), 1401-1405. doi:10.1111/ijcp.12587
Citrome, L. (2014). New treatment targets to improve symptoms in schizophrenia. The Journal of Clinical Psychiatry, 75(8), e22. doi:10.4088/JCP.13049tx6c
